alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
From: Jackiesimpson48@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 3:33:11 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Jacqueline Simpson

Fairfield, OH 45014
Date Globe Highway Primary Globe Highway Secondary 1/3/2011 1/9/2011 1/15/2011 0.01763 0.01993 1/21/2011 0.07925 1/27/2011 0.00524 0.00562

2/2/2011 0.02721 2/8/2011 0.41585 2/14/2011 0.1179 0.12122 2/20/2011 0.35015 0.36741 2/26/2011 0.22075 0.23624

3/4/2011 0.0352 0.0423 3/10/2011 0.0277 0.0277 3/16/2011 0.0624 0.0723 3/22/2011 0.0212 0.0223 3/28/2011 0.2688 0.2654

4/3/2011 0.3902 0.4499 4/9/2011 0.2915 0.2643 4/15/2011 0.0425 4/21/2011 0.2789 0.2944 4/27/2011 0.1447 0.1273

5/3/2011 0.0112 0.0199 5/9/2011 0.4957 0.5238 5/15/2011 0.4737 0.4016 5/21/2011 0.1778 0.184 5/27/2011 0.3765 0.3221

6/2/2011 0.2407 0.2666 6/8/2011 0.4028 0.4156 6/14/2011 0.3338 0.3528 6/20/2011 0.2018 0.2025 6/26/2011 0.1537 0.1476 ADEQ Lead Data for 2011
[Federal Register Volume 88, Number 184 (Monday, September 25, 2023)]
[Notices]
[Pages 65695-65696]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20656]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Investigator Initiated 
Program Project Applications (P01 Clinical Trial Not Allowed).
    Date: November 7, 2023.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G13A, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Mairi Noverr, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, 5601 Fishers Lane, Room 3G13A, Rockville, MD

[[Page 65696]]

20852, (240) 747-7530, <a href="/cdn-cgi/l/email-protection#5d303c342f347333322b382f2f1d333435733a322b"><span class="__cf_email__" data-cfemail="ed808c849f84c383829b889f9fad838485c38a829b">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 19, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-20656 Filed 9-22-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.2





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with this Annual Report on Form 10-K/A of First China Pharmaceutical Group, Inc. (the “Company”) for the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to her knowledge:





1.           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2.           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.





Date:  December 2, 2011By:
/s/ Yi Jia LiName:  Yi Jia LiTitle:  Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
Before the Second Division,

March 6, 1963

No. 67491.

#### English Bicycle Co. et al. *v.*United States,

protests 60/30011, etc. (New York).

Opinion by

Lawrence, J.

In accordance with stipulation of counsel that the merchandise and issues herein are similar in all material respects to those the subject of *United States*v. *Schmidt Pritchard & Co. et al.*(47 CCPA 152, C.A.D. 750), the claim of the plaintiffs was sustained.
#### City of Yonkers, Appellant, *v.*The Federal Sugar Refining Company, Respondent.

*City of Yonkers*v. *Federal Sugar Refining Co.,*136 App. Div. 701, affirmed.

(Argued January 28, 1913;

decided February 11, 1913.)

Appeal from an order of the Appellate Division of the Supreme Court in the second judicial department, entered March 17, 1910, reversing a judgment in favor of plaintiff entered upon the report of a referee and granting a new trial in an action to enjoin defendant from permitting black smoke, soot and dust to escape from chimneys of its plant in the city of Yonkers.

*Thomas F. Curran*for appellant.

*Charles Philip Easton*for respondent.

Order affirmed and judgment absolute ordered against appellant on the stipulation, with costs in all courts, on opinion of Burr, J., below.

Concur: Cullen, Ch. J., Gray, Werner, Chase, Collin, Cuddeback and Miller, JJ.
From: ncpinkhams@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:57:09 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Barbara Pinkham

Washington, NC 27889
No. 67518.

#### Wear Right Gloves, Inc. *v.*United States,

protests 60/28155, etc. (New York).

Opinion by

Eord, J.

In accordance with stipulation of counsel that the merchandise consists of nylon gloves similar in use to gloves in chief value of silk or cotton, the claims of the plaintiff were sustained as follows: The items marked “A” at 30 percent under the provision in paragraph 1208, as modified by the Japanese Protocol to the General Agreement on Tariffs and Trade (T.D. 53865), supplemented by Presidential proclamation (T.D. 53877), for silk gloves, knit or crocheted, the items marked “B” at 30 percent under the provision in paragraph 915, as modified, *supra,*for cotton gloves, made of fabric knit on a *242warp-knitting or other machine, and the items marked “C” at 25 percent under paragraph 915 of the act as cotton gloves, made of woven fabric. *United States*v. *Steinberg Bros.*(47 CCPA 47, C.A.D. 727), followed.
(R.D. 11479)

#### Elof Hansson, Inc. *v.*United States

Entry No. 722368-1/2.

(Decided January 30, 1968)

*Sharp, Solter & Hutchison*for the plaintiff.

*Edwin L. ~Weisl, dr.,*Assistant Attorney General, for the defendant.

Rao, Chief Judge:

This appeal for reappraisement has been submitted for decision upon the following stipulation:

> _ IT IS HEREBY STIPULATED AND AGREED by the undersigned, subject to the approval of the, Court:

> 1. That the subject merchandise consists of hardboard exported from Sweden as to which the Secretary of the Treasury issued a finding of dumping, published in 89 TD 197, TD 53567, made pursuant to the Antidumping Act of 1921 (19 U.S.C., 160, et seq.).

> 2. That pursuant to Section 168 of said Antidumping Act, the appraiser reported the purchase price (Sec. 162) and the foreign market value (Sec. 164) as to the merchandise listed on Schedule A attached hereto and made a part hereof.

> 3. That pursuant to Sections 500 and 402 of the Tariff Act of 1930 as amended, the appraiser appraised all of the merchandise in the appeals for appraisement enumerated on Schedule A for regular duty purposes.

> 4. That the plaintiff duly filed appeals for reappraisement as to the values referred to in the above paragraphs Nos. 2 and 3.

> *7705. That at the times relevant herein the purchase price and the foreign market value under the said Antidumping Act are as specified in the aforesaid Schedule A attached hereto.

> 6. That as to all other items of merchandise not identified on Schedule A, the appraiser’s reports of purchase price and of foreign market value are correct.

> 7. That the appraiser’s findings of value under the provisions of Section 402 of the Tariff Act of 1930 as amended, are correct.

> 8. That said appeals are submitted for decision upon this stipulation and said Schedule A.

Upon the agreed facts, I find foreign market value, as defined in section 164 of the Antidumping Act of 1921 (19 U.S.C. § 164), for the merchandise described in schedule A, annexed to this decision and made a part hereof, and the purchase price thereof, within section 162 of said act (19 U.S.C. § 162), to be as indicated in said schedule. As to all other items of merchandise, not identified in schedule A, I find the foreign market values and purchase prices to be as reported by the appraiser. In all other respects, the values of all merchandise are as returned by the appraiser.

Judgment will be entered accordingly.
MOORE & ASSOCIATES, CHARTERED ACCOUNTANTS AND ADVISORS PCAOB REGISTERED   Exhibit 23.1   CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    We consent to the use, in the statement on Form 10-K of Town & Country Appraisal Service, Inc. of our report dated April 2, 2009 on our audit of the financial statements of Town & Country Appraisal Service, Inc. as of December 31, 2008, and the related statements of operations, stockholders equity and cash flows for the year then ended.          /s/ Moore & Associates, Chartered Moore & Associates Chartered Las Vegas, Nevada April 9, 2009                     6490 West Desert Inn Road, Las Vegas, NV 89146 (702)253-7499 Fax (702)253-7501
Exhibit 32.2




CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Innovative Wireless Technologies, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Pavel Alpatov, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:




(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and




(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





/s/ Pavel AlpatovPavel AlpatovPrincipal Financial OfficerMarch 8, 2011
October 16, 2012



### JUDGMENT 

## The Fourteenth Court of Appeals

HORIZON UNITED GROUP INTERNATIONAL, LLC D /B/A HORIZON GROUP INTERNATIONAL , Appellant

NO. 14

- 12

- 00606

- CV V.

PEARLAND CAPITAL GRO UP, LP , Appellee

________________________________ Today the Court heard appellee's motion to dismiss the appeal from the judgment signed by the court below on June 19, 2012. Having considered the motion and found it meritorious, we order the appeal DISMISSED

. We further order that all costs incurred by reason of this appeal be paid by appellant, Horizon United Group International, LLC d/b/a Horizon Group International.

We further order this decision certified below for observance.
^MS 

Q 

U S. Department 8°° independence Ave.. S.W. 

of Transportation Washington, D.C. 20591 

Federal Aviation 

Administration 

August 18, 2008 

VIA FACSIMILE AND REGULAR MAIL 

David M. Murray, Esq. 

Assistant County Attorney 

Miami-Dade County 

P.O. Box 025504 

Miami, Florida 33102-5504 T: 

— I 

' —-I 

Michael A. Pizzi, Esq. 

15271 N.W. 60 Avenue 

Suite 206A -'c}j 

Miami Lakes, Florida 33014 ^' g 

'•••"'' S 

RE: Alca, et al., v. Miami-Dade County 

FAA Docket No. 16-08-05 

Request for Extension of Time 

Dear Messrs. Murray and Pizzi: 

Counsel for Respondent Miami-Dade County, via request served July 29, 2008, has requested an 

extension of time through September 19,2008 to file an Answer to the 14 CFR Part 16 

Complaint filed in the above-referenced matter. Counsel advises that Counsel for the 

Complainants consented to an extension through September 19, 2008, premised on the 

Respondent engaging in meaningfial discussions with the complaining tenants and agreeing to 

stay pending litigation in Miami-Dade County until the conclusion of the FAA Part 16 

proceeding. Counsel for Respondent states the two conditions are acceptable to the Respondent. 

Although Part 16 is intended to expedite substantially the handling and disposition of airportrelated complaints, the Rules of Practice for Federally Assisted Airport Enforcement 

Proceedings, Final Rule, 61 Fed. Reg. 53998 (October 16, 1996), provide that an extension of 

time may be granted where necessary or appropriate for a fair and complete hearing of the 

matters before the agency. 

While a sixty (60) day extension of time wdll delay issuance of the Director's Determination, the 

denial of said extension of time could result in prejudice if the Respondent is unable to 

adequately respond. In rendering its decision, the FAA may rely entirely on the complaint and 

responsive pleadings. Part 16 requires that each party shall file documents sufficient to present 
all relevant facts and argument necessary for the FAA to determine whether the sponsor is in 

compliance. 

Accordingly, Respondent's request for an extension through September 19, 2008 is granted. 

Respondent's Answer is now due on or before September 19, 2008. The Complainants may file 

a Reply within ten (10) days of the date of service of the Answer. 

Sincerely, 

ElizabOTh Newman 

Attorney, Airports Law Branch 

cc: Part 16 Airport Proceedings Docket 

ACO 100
From: ruth_cole2002@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:10:12 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Ruth Cole

Willow Spring, NC 27592
Exhibit 32.1




CERTIFICATION
PURSUANT TO


18 U.S.C. SECTION
1350,


AS ADOPTED PURSUANT
TO


SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002




In
connection with the Annual Report of Innovative Wireless Technologies, Inc. (the
“Company”) on Form 10-K for the fiscal year ended December 31, 2008 as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, Pavel Alpatov, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant
to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:




(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





/s/
      Pavel AlpatovPavel
      Alpatov
                              Principal
      Executive Officer
                              February
      8,
2011
Exhibit 31.2

CERTIFICATION PURSUANT TO SECTION 302(A)

OF THE SARBANES-OXLEY ACT OF 2002

I, Nick Bonos, certify that:

1. I have reviewed the Annual Report on Form 10-K for the fiscal period ended October 31, 2008 of CurrencySharesSMRussian Ruble
Trust;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;

4. The other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;

(b) Evaluated the effectiveness of the
registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the
registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over
financial reporting; and

5. The other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and PADCO Advisors II, Inc.s auditors and the board of directors of PADCO Advisors II, Inc. and the board of directors of Rydex Fund Services, Inc. and the audit committee of Rydex Specialized
Products LLCs board of managers (or persons performing equivalent functions):

(a) All significant deficiencies and material
weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves persons who have a significant role in the registrants internal control over financial
reporting.

Date: January 29, 2009



|                             
|-----------------------------
|/s/ NICK BONOS               
|Nick Bonos                   
|Chief Financial Officer      
|(principal financial officer)